These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7515300)
41. A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Japan Adult Leukemia Study Group. Ohno R; Tomonaga M; Ohshima T; Masaoka T; Asou N; Oh H; Nishikawa K; Kanamaru A; Murakami H; Furusawa S Int J Hematol; 1993 Aug; 58(1-2):73-81. PubMed ID: 7693029 [TBL] [Abstract][Full Text] [Related]
42. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease. de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878 [TBL] [Abstract][Full Text] [Related]
43. Optimal timing of G-CSF administration after CD34+ immunoselected peripheral blood progenitor cell transplantation. Piccirillo N; Sica S; Laurenti L; Chiusolo P; La Barbera EO; Sorà F; Leone G Bone Marrow Transplant; 1999 Jun; 23(12):1245-50. PubMed ID: 10414910 [TBL] [Abstract][Full Text] [Related]
44. [G-CSF administration following autologous peripheral blood stem cell transplantation--the effect of G-CSF level on neutrophil recovery]. Saigo K; Sugimoto T; Matsuo M; Narita H; Ryo R; Kumagai S Gan To Kagaku Ryoho; 2000 Mar; 27(3):437-42. PubMed ID: 10740638 [TBL] [Abstract][Full Text] [Related]
45. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Kiss JE; Rybka WB; Winkelstein A; deMagalhaes-Silverman M; Lister J; D'Andrea P; Ball ED Bone Marrow Transplant; 1997 Feb; 19(4):303-10. PubMed ID: 9051238 [TBL] [Abstract][Full Text] [Related]
46. G-CSF during large field radiotherapy reduces bone marrow recovery capacity. Pape H; Orth K; Heese A; Heyll A; Kobbe G; Schmitt G; Niederbichler AD; Peiper M; Schwarz A; Boelke E Eur J Med Res; 2006 Aug; 11(8):322-8. PubMed ID: 17052967 [TBL] [Abstract][Full Text] [Related]
47. [Indications of G-CSF administration in hematologic disorders]. Lionne-Huyghe P; Kuhnowski F; Coiteux V; Bauters F; Morschhauser F Bull Cancer; 2006 May; 93(5):453-62. PubMed ID: 16777623 [TBL] [Abstract][Full Text] [Related]
48. [Autotransplantation in acute leukemia using totipotent cells mobilized with filgrastim]. Ruiz-Argüelles GJ; Ruiz-Argüelles A; Alemán-Hoey DD; Arizpe Bravo D; Martin-López A; Ocejo Rodríguez A Rev Invest Clin; 1993; 45(5):479-80. PubMed ID: 7510900 [No Abstract] [Full Text] [Related]
49. Effects of prophylactic hematopoietic colony stimulating factors on stem cell transplantations: meta-analysis. Kim S; Baek J; Min H Arch Pharm Res; 2012 Nov; 35(11):2013-20. PubMed ID: 23212644 [TBL] [Abstract][Full Text] [Related]
50. Neutrophil dynamics in response to chemotherapy and G-CSF. Zhuge C; Lei J; Mackey MC J Theor Biol; 2012 Jan; 293():111-20. PubMed ID: 22037060 [TBL] [Abstract][Full Text] [Related]
51. [Appropriate use of granulocyte colony-stimulating factor in the management of hematologic malignancies]. Usui N Gan To Kagaku Ryoho; 2014 Jun; 41(6):694-701. PubMed ID: 25129082 [TBL] [Abstract][Full Text] [Related]
52. The combination of erythropoietin and granulocyte colony-stimulating factor increases the rate of haemopoietic recovery with clinical benefit after peripheral blood progenitor cell transplantation. Pierelli L; Scambia G; Menichella G; d'Onofrio G; Salerno G; Panici PB; Foddai ML; Vittori M; Lai M; Ciarli M; Puglia G; Mancuso S; Bizzi B Br J Haematol; 1996 Feb; 92(2):287-94. PubMed ID: 8602987 [TBL] [Abstract][Full Text] [Related]
53. Current status of G-CSF in support of chemotherapy and radiotherapy. Miller LL Oncology (Williston Park); 1993 Oct; 7(10):67-78, 81-3; discussion 83-4, 87-8. PubMed ID: 7504501 [TBL] [Abstract][Full Text] [Related]
56. [Appropriate use of granulocyte-colony stimulating factor in treating hematologic malignancies]. Usui N Rinsho Ketsueki; 2015 Oct; 56(10):2267-76. PubMed ID: 26458468 [TBL] [Abstract][Full Text] [Related]
57. Impact of recommended weight-based dosing of granulocyte-colony stimulating factors in acute leukemia and stem cell transplant patients. K Hockings J; K Owolabi D; Broyles JE; C Wheelis S Support Care Cancer; 2017 Jun; 25(6):1853-1858. PubMed ID: 28120115 [TBL] [Abstract][Full Text] [Related]
58. Hematopoietic growth factors--not whether, but when and where. Hoelzer D N Engl J Med; 1997 Jun; 336(25):1822-4. PubMed ID: 9187075 [No Abstract] [Full Text] [Related]
59. Rapid recovery of hematopoiesis in patients given high-dose chemotherapy followed by infusion of refrigerated unprocessed autologous bone marrow and peripheral blood. Aggarwal S; Singh B; Sood SK; Kumra VP; Byotra SP; Sachar VP; Saran RK Transplant Proc; 2000 Nov; 32(7):2460-1. PubMed ID: 11120244 [No Abstract] [Full Text] [Related]
60. In vivo dose-response effect of recombinant human granulocyte colony-stimulating factor on increase in granulocytes after peripheral blood stem cell autotransplantation. Takaue Y; Koyama T; Watanabe T; Kawano Y; Ninomiya T; Kuroda Y; Hiraoka A; Masaoka T Acta Haematol; 1989; 81(4):210-2. PubMed ID: 2474229 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]